Walkner Condon Financial Advisors LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1817494
MADISON, WI
Position in GILD
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$683,373
+$107,636 QoQ
Shares Held
5,409
+30.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#1,240
of 2,266 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Walkner Condon Financial Advisors LLC holds $5,850,924 across 8 Drug Manufacturers - General names. GILD ranks #4 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,536 | $1,842,324 | |
| 2 | JNJ |
Johnson & Johnson
|
4,063 | $1,031,880 | |
| 3 | ABBV |
AbbVie Inc.
|
2,816 | $708,618 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
5,409 | $683,373 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,354 | $559,489 | |
| 6 | NVS |
Novartis AG
|
2,701 | $423,300 | |
| 7 | AMGN |
Amgen Inc
|
1,035 | $374,794 | |
| 8 | PFE |
Pfizer Inc
|
9,433 | $227,146 |
All Filings in GILD
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $683,373 | 5,409 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $575,737 | 4,131 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $491,573 | 4,005 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $437,451 | 3,941 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $397,579 | 3,586 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $390,270 | 3,483 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $318,861 | 3,452 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $284,720 | 3,396 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $213,377 | 3,110 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $225,024 | 3,072 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $243,921 | 3,011 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $219,124 | 2,924 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $244,928 | 3,178 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $235,219 | 2,835 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $225,098 | 2,622 | Shares | Sole | 2023-01-26 | |
| No filing history on record for this holder in this stock. | ||||||